Gothenburg, Sweden

Oscar Emil Nilsson


 

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Oscar Emil Nilsson: Innovator in Drug Delivery Technology

Introduction

Oscar Emil Nilsson is a notable inventor based in Gothenburg, Sweden. He has made significant contributions to the field of drug delivery systems, particularly through his innovative designs and patents. His work focuses on improving the efficiency and effectiveness of dispensing medications in pellet form.

Latest Patents

Oscar holds a patent for a "Delivery device for drug pellets." This device is designed to dispense one or more drugs in pellet form. It includes a cartridge with a chamber that contains a plurality of drugs in pellet form. A screw pump is configured to receive the pellets from the chamber and, upon rotation, transport them to be dispensed from the device. Additionally, a rotating member extends through the cartridge and is designed to rotate the screw pump to facilitate the dispensing of the pellets.

Career Highlights

Oscar Emil Nilsson is currently associated with Ondosis AB, a company that specializes in innovative drug delivery solutions. His work at Ondosis AB has been instrumental in advancing the technology used in medical applications. With a focus on practical and efficient designs, he continues to contribute to the field of pharmaceuticals.

Collaborations

Oscar collaborates with talented individuals such as Robert Axelsson and Ronny Brakhya. Their combined expertise enhances the innovative capabilities of their projects and contributes to the success of their endeavors.

Conclusion

Oscar Emil Nilsson is a pioneering inventor whose work in drug delivery technology is making a significant impact in the medical field. His patent for a delivery device for drug pellets exemplifies his commitment to improving healthcare solutions. Through his career at Ondosis AB and collaborations with skilled professionals, he continues to push the boundaries of innovation in pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…